Expression of death-associated protein kinase during tumour progression of human renal cell carcinomas: hypermethylation-independent mechanisms of inactivation.

[1]  P. Malfertheiner,et al.  Promoter hypermethylation of p16INK4a, E-cadherin, O6-MGMT, DAPK and FHIT in adenocarcinomas of the esophagus, esophagogastric junction and proximal stomach. , 2005, International journal of oncology.

[2]  F. Chan,et al.  Promoter hypermethylation of Death-associated protein-kinase gene associated with advance stage gastric cancer. , 2005, Oncology reports.

[3]  Jia-Ren Lin,et al.  Bidirectional signals transduced by DAPK–ERK interaction promote the apoptotic effect of DAPK , 2005, The EMBO journal.

[4]  Li Mao,et al.  Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells. , 2004, Molecular cancer research : MCR.

[5]  Tsuyoshi Saito,et al.  Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: Promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. , 2004, Human pathology.

[6]  U. Lehmann,et al.  Low level of DAP-kinase DNA methylation in myelodysplastic syndrome. , 2004, Blood.

[7]  A. Kimchi,et al.  DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation , 2004, Cell Death and Differentiation.

[8]  D. Altieri.  Survivin, versatile modulation of cell division and apoptosis in cancer , 2003, Oncogene.

[9]  Suzanne Cory,et al.  The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.

[10]  R. Korneluk,et al.  The inhibitors of apoptosis: there is more to life than Bcl2 , 2003, Oncogene.

[11]  L. Hesson,et al.  Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma , 2003, Oncogene.

[12]  S. Lam,et al.  Epigenetic down-regulation of death-associated protein kinase in lung cancers. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[13]  M. Esteller.  CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future , 2002, Oncogene.

[14]  C. Suschek,et al.  Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas , 2002, International journal of cancer.

[15]  Kenichi Harada,et al.  Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines , 2002, Oncogene.

[16]  M. Toyota,et al.  DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers , 2002, British Journal of Cancer.

[17]  A. Kimchi,et al.  DAP kinase and DRP-1 mediate membrane blebbing and the formation of autophagic vesicles during programmed cell death , 2002, The Journal of cell biology.

[18]  W. Farrell,et al.  Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion , 2002, Oncogene.

[19]  M. Eisenstein,et al.  The Pro-apoptotic Function of Death-associated Protein Kinase Is Controlled by a Unique Inhibitory Autophosphorylation-based Mechanism* , 2001, The Journal of Biological Chemistry.

[20]  E. Mark,et al.  Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer , 2001, Oncogene.

[21]  Y. Tomita,et al.  Role of Hypermethylation of DAP-Kinase CpG Island in the Development of Thyroid Lymphoma , 2000, Laboratory Investigation.

[22]  P. Wernet,et al.  Novel mutations of the von Hippel‐Lindau tumor‐suppressor gene and rare DNA hypermethylation in renal‐cell carcinoma cell lines of the clear‐cell type , 2000, International journal of cancer.

[23]  P. Krammer,et al.  Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma , 2000, British Journal of Cancer.

[24]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[25]  A. Kimchi,et al.  Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain , 1999, The Journal of cell biology.

[26]  J. Herman,et al.  Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. , 1999, Blood.

[27]  E. Koonin,et al.  The domains of death: evolution of the apoptosis machinery. , 1999, Trends in biochemical sciences.

[28]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[29]  A. Kimchi.  DAP genes: novel apoptotic genes isolated by a functional approach to gene cloning. , 1998, Biochimica et Biophysica Acta.

[30]  S. Polak‐Charcon,et al.  DAP kinase links the control of apoptosis to metastasis , 1997, Nature.

[31]  Peter A. Jones,et al.  DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: possible implications for role as tumor suppressor gene , 1997, Oncogene.

[32]  P. Jones,et al.  Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. , 1997, Carcinogenesis.

[33]  A. Kimchi,et al.  DAP‐kinase is a Ca2+/calmodulin‐dependent, cytoskeletal‐associated protein kinase, with cell death‐inducing functions that depend on its catalytic activity , 1997, The EMBO journal.

[34]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[35]  R. Moll,et al.  Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines. , 1996, British Journal of Cancer.

[36]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Störkel,et al.  Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma. , 1995, The American journal of pathology.

[38]  A. Levine,et al.  The p53 tumour suppressor gene , 1991, Nature.

[39]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[40]  W. Thoenes,et al.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. , 1986, Pathology, research and practice.

[41]  R. Moll,et al.  Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type , 2004, Virchows Archiv.

[42]  Jia-Yun Chen,et al.  TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase , 2002, Nature Cell Biology.

[43]  Gustavo Droguett,et al.  DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation , 2000, Nature Cell Biology.

[44]  J. Herman,et al.  Alterations in DNA methylation: a fundamental aspect of neoplasia. , 1998, Advances in cancer research.

[45]  C. Rudin,et al.  Apoptosis and disease: regulation and clinical relevance of programmed cell death. , 1997, Annual review of medicine.

[46]  A. Kimchi,et al.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.